Table 12.6e

Immunosuppression Use for Maintenance

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Functioning Graft at Discharge		753	801	859	951	947	1,013	1,108	1,289	1,302	1,361
With Immunosuppression Info		751	789	854	948	942	1,009	1,098	1,271	1,296	1,325
Corticosteroids	Any in Category	97.3%	98.1%	97.8%	98.9%	98.6%	94.4%	97.2%	98.0%	97.5%	95.3%
Corticosteroids	Steroids	97.3%	98.1%	97.8%	98.9%	98.6%	94.4%	97.2%	98.0%	97.5%	95.3%
Cyclosporine	Any in Category	73.4%	66.7%	61.9%	52.1%	42.5%	34.6%	29.7%	22.3%	16.2%	10.1%
	Cyclosporin	0.0%	0.0%	0.0%	0.4%	0.2%	0.2%	0.2%	0.5%	1.1%	1.1%
	Sandimmmune	11.9%	10.8%	6.9%	5.7%	4.5%	4.8%	2.1%	1.7%	1.6%	0.8%
	Neoral	61.5%	55.8%	54.0%	39.3%	31.0%	23.0%	20.4%	15.1%	9.3%	6.9%
	Gengraf	0.0%	0.0%	1.1%	6.2%	6.7%	6.5%	6.7%	4.8%	4.2%	1.4%
	Eon	0.0%	0.1%	0.0%	0.4%	0.1%	0.1%	0.3%	0.2%	0.0%	0.0%
Tacrolimus	Any in Category	26.6%	29.9%	38.3%	49.4%	57.2%	65.4%	69.9%	76.1%	82.6%	87.5%
Tacrolimus	Tacrolimus	26.6%	29.9%	38.3%	49.4%	57.2%	65.4%	69.9%	76.1%	82.6%	87.5%
Antimetabolites	Any in Category	92.1%	91.8%	93.7%	91.8%	91.1%	89.6%	90.6%	92.1%	92.7%	92.2%
	Mycophenolate Mofetil	22.1%	27.5%	35.6%	41.4%	45.1%	43.5%	46.7%	51.5%	51.9%	54.3%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.1%	2.5%	6.4%
	Azathioprine	69.9%	64.0%	57.8%	50.2%	45.8%	46.1%	43.9%	38.3%	38.3%	31.5%
	Leflunomide	0.0%	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%
	Cytoxan	0.1%	0.3%	0.1%	0.1%	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	0.1%	0.6%	2.6%	4.2%	1.9%	1.1%	1.3%	0.6%	1.7%	0.2%
	Sirolimus	0.1%	0.6%	2.6%	4.2%	1.9%	1.1%	1.3%	0.6%	1.7%	0.2%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%